Pier Constantini
Building a better drug
Laura Cancedda, Marco De Vivo and Andrea Malizia, the founders of Iama Therapeutics are hoping a new class of molecule will prove successful in a drug to treat autism. Bold portraits show the founders as leaders in drug development who understand the gravity of their work.
